02609nas a2200301 4500000000100000008004100001260001500042653005100057653002200108653002300130100001400153700001200167700001400179700001000193700001400203700001200217700001400229700002400243700001500267700001300282700001600295700001400311700001300325700002000338245010800358856011400466520172700580 2025 d bThe Lancet10aglobal action plan on antimicrobial resistance10agender commitment10aequity commitment 1 aBatheja D1 aSaint V1 aDobreva Z1 aGoe S1 aLewycka S1 aMutua E1 a Nayiga S1 aPaulin-Deschenaux S1 aSimpson SJ1 aSteege R1 a Westwood E1 aCharani E1 aMpundu M1 a Balachandran A00aIntegrating gender and equity commitments in the revised global action plan on antimicrobial resistance uhttps://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01377-7/abstract?dgcid=raven_jbs_aip_email3 a

Since its introduction in 2015, the global action plan (GAP) on antimicrobial resistance (AMR) has guided the global response to AMR1 and the development of 178 national action plans (NAPs). However, GAP and most NAPs do not recognise key social and structural drivers of AMR.2,3 This is despite growing evidence on the crucial role of gender inequity and broader socioeconomic dimensions in driving AMR and undermining efforts to address it.4–6 Recent high-level strategies and declarations from WHO and the UN emphasise the need for a people-centred approach to address gender and equity dimensions of AMR.3,7–9 As GAP undergoes revision in 2025–26, we suggest human health priority areas to explicitly integrate gender and social determinants of health equity aligned with the 2015 GAP objectives (table). These priorities are informed by evidence, and broader universal health coverage, primary health care, and Sustainable Development Goals commitments to “leaving no one behind”.